Corteria Pharmaceuticals
Home page - Corteria
Founded 2021 · $84.2M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- corteriapharma.com
- Total Funding
- $84.2M
- Last Round
- $71.0M Series ASep 2023
- Rounds
- 2
About
Privately held pharma company developing first-in-class drugs for cardiovascular and high-unmet-need indications, founded 2021.
Summary
Corteria Pharmaceuticals is a Biotech company, founded in 2021. It has raised $84.2M in total across 2 rounds, most recently a $71.0M Series A round in Sep 2023. Investors include OrbiMed, Jeito Capital and Kurma Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...